Abstract
Oxidized phospholipids (OxPL) appear in the lung circulation as a result of increased oxidative stress that accompanies pathological conditions such as acute lung injury, lung inflammation, adult respiratory distress syndrome (ARDS), ventilator-induced lung injury (VILI), systemic inflammatory response syndrome (SIRS) and sepsis. Under these conditions, lung vascular barrier function is largely compromised. The severity of vascular endothelial dysfunction is determined by a balance between barrier-disruptive and barrier-protective agents present in the pulmonary circulation. Oxidation of phospholipids such as 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC) generates a group of bioactive oxidized phospholipid species that demonstrate a wide spectrum of physiological effects including activation of monocyte adhesion to endothelial cells and attenuation of inflammatory cascades triggered by bacterial lipopolysaccharide (LPS). Moreover, our studies and other previous reports strongly suggest barrier-protective effects of OxPAPC on human pulmonary EC, and EC from systemic circulation. In this review, we will discuss a potential role for biologically active oxidized phospholipids in the regulation of vascular barrier integrity and LPS-induced inflammation in the injured lung.
Keywords: Oxidized phospholipids, lung injury, inflammation, endothelial permeability, signal transduction, cytoskeleton
Current Respiratory Medicine Reviews
Title: Role of Oxidized Phospholipids in Acute Lung Injury
Volume: 2 Issue: 1
Author(s): Valery N. Bochkov, Norbert Leitinger and Konstantin G. Birukov
Affiliation:
Keywords: Oxidized phospholipids, lung injury, inflammation, endothelial permeability, signal transduction, cytoskeleton
Abstract: Oxidized phospholipids (OxPL) appear in the lung circulation as a result of increased oxidative stress that accompanies pathological conditions such as acute lung injury, lung inflammation, adult respiratory distress syndrome (ARDS), ventilator-induced lung injury (VILI), systemic inflammatory response syndrome (SIRS) and sepsis. Under these conditions, lung vascular barrier function is largely compromised. The severity of vascular endothelial dysfunction is determined by a balance between barrier-disruptive and barrier-protective agents present in the pulmonary circulation. Oxidation of phospholipids such as 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC) generates a group of bioactive oxidized phospholipid species that demonstrate a wide spectrum of physiological effects including activation of monocyte adhesion to endothelial cells and attenuation of inflammatory cascades triggered by bacterial lipopolysaccharide (LPS). Moreover, our studies and other previous reports strongly suggest barrier-protective effects of OxPAPC on human pulmonary EC, and EC from systemic circulation. In this review, we will discuss a potential role for biologically active oxidized phospholipids in the regulation of vascular barrier integrity and LPS-induced inflammation in the injured lung.
Export Options
About this article
Cite this article as:
Bochkov N. Valery, Leitinger Norbert and Birukov G. Konstantin, Role of Oxidized Phospholipids in Acute Lung Injury, Current Respiratory Medicine Reviews 2006; 2 (1) . https://dx.doi.org/10.2174/157339806775486182
DOI https://dx.doi.org/10.2174/157339806775486182 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ocular Toxocariasis: New Diagnostic and Therapeutic Perspectives
Recent Patents on Anti-Infective Drug Discovery Endogenous Cardioprotective Agents: Role in Pre and Postconditioning
Current Drug Targets Involvement of the Toxic AGEs (TAGE)-RAGE System in the Pathogenesis of Diabetic Vascular Complications: A Novel Therapeutic Strategy
Current Drug Targets Successful Treatment of Pulmonary Hemorrhage Associated with Pediatric Tsutsugamushi Disease by Chloromycetin
Current Signal Transduction Therapy Macrolides Allergy
Current Pharmaceutical Design Management of Connective Tissue Interstitial Lung Disease
Current Respiratory Medicine Reviews Lycopene and Cardiovascular Diseases: An Update
Current Medicinal Chemistry Anti-Inflammatory Drugs and Statins for Arterial Stiffness Reduction
Current Pharmaceutical Design Recent Advances in the Design and Synthesis of Prednisolone and Methylprednisolone Conjugates
Current Pharmaceutical Design Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences
Current Drug Therapy Lipid-based Nano-phytomedicines for Disease Treatment and Theranostic Applications
Current Nanomedicine Outcome of 27 Patients with Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Patients in Iran
Current Respiratory Medicine Reviews Imaging Neuroinflammation in Ischemic Stroke and in the Atherosclerotic Vascular Disease
Current Vascular Pharmacology Nitric Oxide and Cyclic GMP Signaling Pathway as a Focus for Drug Development
Current Medicinal Chemistry Sigma-1 Receptors: Potential Targets for the Treatment of Substance Abuse
Current Pharmaceutical Design Near Infrared Spectroscopy in Healthy Preterm and Term Newborns: Correlation with Gestational Age and Standard Monitoring Parameters
Current Neurovascular Research Heart Failure in Sub-Saharan Africa
Current Cardiology Reviews Oncogenic Fusion Tyrosine Kinases as Molecular Targets for Anti-Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Nitrofurantoin Pulmonary Toxicity: Neglected Threat
Current Drug Safety Genistein: A Phytoestrogen with Multifaceted Therapeutic Properties
Mini-Reviews in Medicinal Chemistry